Tag Archives: M.C.

M.C. Escher By Way of Generic Drug Pricing

By Sara W. Koblitz — Though FDA does not have the legal authority to control or even directly address drug prices, Commissioner Gottlieb has certainly not shied away from the issue.  In fact, drug (and biologic) competition and accessibility is … Continue reading

Posted in Products Liability | Tagged , , , , | Leave a comment